Dr. Roy Mano

Department of Urology at Memorial Sloan Kettering and Duke University Medical School, May 2015

My name is Roy Mano, and I am a 36 year old physician working as a resident in the Department of Urology at Rabin Medical Center, Beilinson campus in Petah-Tikva, Israel. I have been a resident in the department for the last 5 years and am approaching the last year of my residency.

I graduated from The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa in 2004. Prior to my residency I served as a medical officer in the Israeli Defense Forces. During this period I had the privilege to serve as a battalion physician in the paratroopers after which I served as a physician in the IDF Special Forces.

I have had a special interest in the field of urologic oncology since the beginning of my residency. The possibility to help people in their battle against cancer and the opportunity to advance medical research within this field are of great importance to me. As part of my residency program, I completed a basic research year focused on the genetics of kidney cancer.  Furthermore, I wish to engage in a fellowship program in this field upon completion of my residency.

In order to further advance my knowledge in urologic oncology, I will take part in a two weeks observership focused on the treatment of high-risk prostate cancer at Memorial Sloan Kettering Cancer Center in May 2015, part of which will be spent in the American Urologic Association annual conference in New Orleans. The purpose of this period is to observe the management of high-risk prostate cancer patients in a leading cancer center, and learn about novel and ongoing research in this field. Currently more patients with high risk prostate cancers are being treated definitively, and may benefit the most from this treatment, therefore the importance of this observation period. During this time I will join the prostate service at MSKCC, which is led by Dr. James A. Eastham Chief of the Urology Service.

The knowledge gained could later be useful in order to improve the management of patients with high risk prostate cancer at Rabin Medical Center, and hopefully engage in research in this field.

I appreciate the help your organization has been offering our hospital throughout the years.

Past Fellows